Femasys Inc.’s Post

View organization page for Femasys Inc., graphic

6,979 followers

"Over 100 years of stagnant innovation could lead to a $20 billion market expansion opportunity for FemBloc in the U.S. alone as we look to address the needs of the over 13 million women who no longer intend to have children.” CEO Kathy Lee-Sepsick shares market insights with @Benzinga and Femasys' vision for transforming women's health with commercially available products like FemaSeed, FemVue, FemCath, and FemCerv.

James Liu

Professor Emeritus, Dept of Reproductive Biology, Case Western Reserve University

2w

Well said!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics